What is Aragen Bioscience?
Aragen Bioscience, headquartered in Morgan Hill, California, operates as a prominent contract research organization (CRO). The company specializes in providing a comprehensive suite of in vitro and in vivo services essential for the discovery, development, and characterization of biologic and diagnostic products. Their offerings span critical stages from initial discovery and cell line development to production, activity assessment, and efficacy evaluation, positioning them as a key partner for companies advancing novel therapeutics and diagnostics.
How much funding has Aragen Bioscience raised?
Aragen Bioscience has raised a total of $2.7M across 1 funding round:
Series B
$2.7M
Series B (2015): $2.7M, investors not publicly disclosed
What's next for Aragen Bioscience?
With the recent infusion of capital, Aragen Bioscience is poised for accelerated growth and expansion of its service capabilities. The enterprise-level backing suggests a strategic focus on scaling operations, potentially enhancing its technological infrastructure, and broadening its market reach. This strategic financing will likely enable Aragen Bioscience to further solidify its position as a leading CRO, supporting the advancement of complex biologic and diagnostic projects for a global clientele.
See full Aragen Bioscience company page
